Scan to download
BTC $76,714.33 -0.13%
ETH $2,126.98 +0.46%
BNB $642.76 -0.14%
XRP $1.38 -0.96%
SOL $84.93 -0.00%
TRX $0.3563 -0.01%
DOGE $0.1042 -2.19%
ADA $0.2512 +0.10%
BCH $380.19 -1.46%
LINK $9.68 +1.45%
HYPE $47.35 +3.82%
AAVE $88.82 +0.05%
SUI $1.05 +0.86%
XLM $0.1466 -2.00%
ZEC $563.16 +6.60%
BTC $76,714.33 -0.13%
ETH $2,126.98 +0.46%
BNB $642.76 -0.14%
XRP $1.38 -0.96%
SOL $84.93 -0.00%
TRX $0.3563 -0.01%
DOGE $0.1042 -2.19%
ADA $0.2512 +0.10%
BCH $380.19 -1.46%
LINK $9.68 +1.45%
HYPE $47.35 +3.82%
AAVE $88.82 +0.05%
SUI $1.05 +0.86%
XLM $0.1466 -2.00%
ZEC $563.16 +6.60%

Data: Pioneer Pharmaceutical Biotechnology surged over 240% during trading, having previously announced plans to acquire all shares of Conflux

2025-07-02 10:58:01
Collection

ChainCatcher news, Hong Kong listed company Pioneer Pharma Biotechnology (00399) saw a significant increase in trading volume this morning, with a peak rise of nearly 240%, reaching a maximum price of 0.7 HKD, before retreating to around 0.34 HKD.

Previously, the company announced plans to acquire 100% equity of the blockchain project Conflux to expand its presence in the blockchain field, with two founding members of Conflux currently serving as its executive directors.

app_icon
ChainCatcher Building the Web3 world with innovations.